News
Fintel reports that on June 24, 2025, Jefferies initiated coverage of Cardiff Oncology (NasdaqCM:CRDF) with a Hold ...
In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...
The Beat AML Master Trial found high remission rates and promising safety with triplet therapy in patients with acute myeloid leukemia (AML), according to Ashley Yocum, PhD.
Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after ...
Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...
Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...
Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...
Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...
Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...
Some prior studies have suggested that CBD could help reduce problematic behaviors in children with autism. However, no controlled clinical trials have addressed safety, tolerability and efficacy of ...
CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results